Name: Anaphylm (dibutepinephrine) in Type I allergic reactions including anaphylaxis: Trigger avoidance and allergen immunotherapy
Published: 2026-09-21T21:39:21-04:00

Product information and disease description Place of product in therapy Approaches to treatment Current treatment options and standard of care

Trigger avoidance and allergen immunotherapy

5 evidence topics · 3 sources

Guideline recommendation on allergen avoidance and education

“We recommend clinicians educate patients on avoidance of potential exposure to their allergen(s).” (opens the source at this quote in a new tab)
“We recommend clinicians educate patients that the main route of food-induced anaphylaxis is by ingestion and not contact or inhalation.” (opens the source at this quote in a new tab)

Burden associated with avoidance

“Vigilant avoidance prevents anaphylaxis recurrence from culprit allergens. However, it can be frustrating and associated with impaired quality of life, including bullying of food-allergic children, fear of anaphylaxis during airline travel, and anxiety over restrictions on exercise.” (opens the source at this quote in a new tab)

Venom immunotherapy and specialist referral

“Guidelines recommend that patients with anaphylaxis be referred to an allergy/immunology specialist for confirmation of the suspected trigger, advice on prevention and, where indicated, consideration for allergen immunotherapy (eg, insect venom).” (opens the source at this quote in a new tab)

Oral immunotherapy for food-induced anaphylaxis

“Allergen immunotherapy can help prevent food-induced anaphylaxis by raising the threshold for clinical reactions and encouraging immune tolerance.” (opens the source at this quote in a new tab)
“Although oral immunotherapy (OIT) is not yet advised for routine practice because of concerns about its safety and standardization,” (opens the source at this quote in a new tab)
“Beyond showing clinical benefit, OIT has been linked to a very low rate of severe adverse reactions that would require adrenaline use during home treatment (0.0-0.04%). Successfully completed OIT may lower the risk of anaphylaxis from accidental allergen exposure.” (opens the source at this quote in a new tab)

Immunotherapy does not remove the need for rescue epinephrine

“Food oral immunotherapy (OIT) is a relatively new and promising therapy for food allergy; however, safety and tolerability concerns continue to limit its use in routine clinical practice. Many reactions to OIT are mild and resolve without intervention or with antihistamine alone. However, virtually all clinical trials report some severe allergic reactions.” (opens the source at this quote in a new tab)